SBIR CONCEPT AWARD-NANOSPONGE LINKED DCLK1 INHIBITORS FOR THE TARGETED TREATMENT OF CHOLANGIOCARCINOMA

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID: 75N91023C00008
Contractor
Awarding agency: Department of Health and Human Services
Sub-agency / office: National Institutes of Health
Award amount: $353,412
Period of performance: Feb 28, 2023 – Feb 27, 2024
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC: PSC AN12
Place of performance: MO

Discover comparable awards, related contractors, and agency purchasing history.

Same agency and NAICS · 75A50126C00010 — THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, RE… · Department of Health and Human Services · $96,058,494
Same agency and NAICS · 75A50126C00011 — DEVELOP AND VALIDATE THE OXOS X3, A PORTABLE X-RAY SYSTEM DESIGNED TO TRANSFORM TRAUMA RESPONSE BY BRINGING… · Department of Health and Human Services · $24,445,826
Same agency and NAICS · 75F40126C00096 — EO-14398-A LONG-TERM VASCULAR MPS TO ASSESS CYCLIC CARDIOVASCULAR TOXICITY OF ONCOLOGY DRUGS · Department of Health and Human Services · $2,998,734
Same agency and NAICS · 75F40126C00056 — BAA FY26C1CP12: FDA, CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH), ESTIMATION OF IN-VIVO TISSUE PROPER… · Department of Health and Human Services · $2,456,000
Same agency and NAICS · 75F40126C00083 — BAA FY26C3AP4: A CROSS-SPECIES IMMUNE ORGAN CHIP REFERENCE FRAMEWORK FOR REGULATORY EVALUATION OF VACCINE A… · Department of Health and Human Services · $1,500,000
Same agency and NAICS · 75F40126C00112 — EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP3 - ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIEN… · Department of Health and Human Services · $1,456,427